Skip to Main content Skip to Navigation
Journal articles

In vitro activity of dermaseptin S4 derivatives against genital infections pathogens.

Abstract : Objectives: Sexually transmitted infections present a great risk to the reproductive health of women. Therefore, female-controlled vaginal products directed toward disease prevention are needed urgently. In the present study, efforts were made to evaluate the antimicrobial potency of dermaseptin DS4, an antimicrobial peptide derived from frog skin. To assess the structure-activity relationship between the native DS4 and their derivatives, a set of chemically modified peptides was synthesized and evaluated. Methods: Different strains of bacteria and fungi were used to detect the antimicrobial activity of the new compounds. HeLa cultures were used to determine the safety of compounds towards their toxicity. Results: All DS4 derivatives elicited concentration-dependent antimicrobial activity at micrograms concentrations (MIC values: 4mug/mL-lmg/mL). K4S4(1-28) and K4S4(1-16)a were the most active peptides whereas S4(6-28) was the less one. The order was K4S4(1-28)>K4S4(1-16)a>S4a>S4>S4(6-28). In cytotoxicity assay, some compounds were found to be significantly safer than current antibiotics. Our data also show that increasing the number of positive charges of the peptide resulted in a reduced cytotoxicity without affecting the antimicrobial effect. Conclusions: This study indicates that dermaseptins are antimicrobial molecules that deserve to be tested as topical microbicide with useful associated activities that can add to their prophylaxis, safety and effectiveness.
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-00285772
Contributor : Mireille Gau <>
Submitted on : Friday, June 6, 2008 - 11:25:26 AM
Last modification on : Monday, January 13, 2020 - 5:08:05 PM

Identifiers

Collections

Citation

Amira Zairi, Frédéric Tangy, Souhir Saadi, Khaled Hani. In vitro activity of dermaseptin S4 derivatives against genital infections pathogens.. Regulatory Toxicology and Pharmacology, Elsevier, 2008, 50 (3), pp.353-8. ⟨10.1016/j.yrtph.2008.01.005⟩. ⟨pasteur-00285772⟩

Share

Metrics

Record views

167